A recent analysis from the large ADAPTABLE trial published in JAMA Cardiology showed that enteric coating on aspirin does not change effectiveness or safety for patients with cardiovascular disease.

Opting for enteric-coated aspirin over the uncoated pills doesn’t appear to have a major impact on the drug’s antiplatelet effects in patients with atherosclerotic CVD, but nor did it offer an edge in ...

An enteric coating did not hurt the effectiveness of aspirin pills for secondary prevention of atherosclerotic cardiovascular disease (ASCVD), but it didn't make it any safer either, researchers found ...

This was a post hoc analysis of the 2021 open-label randomized ADAPTABLE (Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term Effectiveness) trial that showed no statistical ...

DEAR MAYO CLINIC: I take low-dose aspirin each day to prevent heart trouble, based on my health care provider’s recommendation. Should I take enteric-coated aspirin to protect my stomach? ANSWER: It ...